PRECISION BIOSCIENCES INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
PRECISION BIOSCIENCES INC (DTIL) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-03-12
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-09-30 was 3.44%.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-06-30 was 4.50%, a 23.63% increase year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-06-30 was 3.64%, a 25.52% increase year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 3.83%, a 107.03% increase year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 0.00%, a 100.00% decline from fiscal 2024.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 3.67%, a 5.66% decline from fiscal 2023.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.89%, a 51.36% increase from fiscal 2022.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.57%, a 140.19% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2024-12-31 | 3.67% 10-K · filed 2026-03-12 | |||
| 2024-09-30 | 3.44% 10-Q · filed 2024-11-04 | 3.67% 10-Q · filed 2024-11-04 | ||
| 2024-06-30 | 4.50% 10-Q · filed 2024-08-01 | 4.50% 10-Q · filed 2024-08-01 | ||
| 2023-12-31 | 3.89% 10-K · filed 2025-03-26 | |||
| 2023-09-30 | 3.71% 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | 3.64% 10-Q · filed 2023-08-04 | 3.71% 10-Q · filed 2023-08-04 | ||
| 2023-03-31 | 3.83% 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 2.57% 10-K · filed 2024-03-27 | |||
| 2022-09-30 | 3.11% 10-Q · filed 2022-11-08 | 2.42% 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | 2.90% 10-Q · filed 2022-08-08 | 2.35% 10-Q · filed 2022-08-08 | ||
| 2022-03-31 | 1.85% 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | 1.07% 10-K · filed 2023-03-09 | |||
| 2021-09-30 | 0.96% 10-Q · filed 2021-11-10 | 0.99% 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | 1.01% 10-Q · filed 2021-08-12 | 0.99% 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 0.66% 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 0.60% 10-K · filed 2022-03-15 | |||
| 2020-09-30 | 0.39% 10-Q · filed 2020-11-10 | 0.61% 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | 0.54% 10-Q · filed 2020-08-13 | 0.69% 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | 1.49% 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | 1.98% 10-K · filed 2021-03-18 | |||
| 2019-09-30 | 1.74% 10-Q · filed 2019-11-12 | 2.08% 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | 2.42% 10-Q · filed 2019-08-14 | 2.45% 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | 2.50% 10-Q · filed 2019-04-29 | |||
| 2018-12-31 | 2.95% 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |